Ark, a Singapore-based medtech enterprise focused on early cancer detection, has raised a record US$ 40 million in Series A funding. Ark’s vision is “a world without late-stage cancer” and its mission is to eliminate late-stage cancer related death by 2048 through the introduction of accurate, affordable, and actionable cancer detection technologies. This record-breaking Series… Read More »
The Food and Drug Administration is blessing a public database for use by genetic test developers that are submitting premarket submissions. The agency says the database is recognized as a source of valid scientific evidence that now can be used by developers of genetic tests to support clinical validity in premarket submissions to the agency.… Read More »
How will screening for intelligence affect parents’ decisions?ERproductions Ltd/Getty By Clare Wilson THE prospect of creating intelligent designer babies has been the subject of ethical debate for decades, but we have lacked the ability to actually do it. That may now change, thanks to a new method of testing an embryo’s genes that could soon… Read More »
DNA from tumours could reveal cancers earlier Medicshots / Alamy By Alice Klein A simple blood test can detect eight different types of cancer. It does this by detecting the various sizes of tumour DNA fragments that flow through the body. At the moment, most cancer screening tools are limited to specific areas of the body –… Read More »
What is a PTEN genetic test? A PTEN genetic test looks for a change, known as a mutation, in a gene called PTEN. Genes are the basic units of heredity passed down from your mother and father. The PTEN gene helps stop the growth of tumors. It’s known as a tumor suppressor. A tumor suppressor… Read More »